Global Oral Antiviral Medications for COVID-19 Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Antiviral Medications for COVID-19 Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Lagevrio and Paxlovid have both been found to be effective in treating mild to moderate COVID-19 in adults aged 18 years of age and older, who do not require supplemental oxygen, and who are at increased risk of progression to hospitalisation. The advantage of these oral medications is that many people will be able to receive treatment for COVID-19 in their own homes without the need to travel to hospital for treatment as an inpatient.
Oral Antiviral Medications for COVID-19 report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Antiviral Medications for COVID-19 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Antiviral Medications for COVID-19 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Antiviral Medications for COVID-19 key manufacturers include Pfizer, Merck, Shionogi, Frontier Biotechnologies, Simcere Pharmaceutical and Guangdong Zhongsheng, etc. Pfizer, Merck, Shionogi are top 3 players and held % sales share in total in 2022.
Oral Antiviral Medications for COVID-19 can be divided into Tablet and Capsule, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Antiviral Medications for COVID-19 is widely used in various fields, such as Hospital and Clinics, etc. Hospital provides greatest supports to the Oral Antiviral Medications for COVID-19 industry development. In 2022, global % sales of Oral Antiviral Medications for COVID-19 went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Antiviral Medications for COVID-19 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
Merck
Shionogi
Frontier Biotechnologies
Simcere Pharmaceutical
Guangdong Zhongsheng
Segment by Type
Tablet
Capsule
Hospital
Clinics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Antiviral Medications for COVID-19 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Antiviral Medications for COVID-19, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Antiviral Medications for COVID-19 industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Antiviral Medications for COVID-19 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Antiviral Medications for COVID-19 introduction, etc. Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Antiviral Medications for COVID-19 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Oral Antiviral Medications for COVID-19 report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Antiviral Medications for COVID-19 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Antiviral Medications for COVID-19 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Antiviral Medications for COVID-19 key manufacturers include Pfizer, Merck, Shionogi, Frontier Biotechnologies, Simcere Pharmaceutical and Guangdong Zhongsheng, etc. Pfizer, Merck, Shionogi are top 3 players and held % sales share in total in 2022.
Oral Antiviral Medications for COVID-19 can be divided into Tablet and Capsule, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Antiviral Medications for COVID-19 is widely used in various fields, such as Hospital and Clinics, etc. Hospital provides greatest supports to the Oral Antiviral Medications for COVID-19 industry development. In 2022, global % sales of Oral Antiviral Medications for COVID-19 went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Antiviral Medications for COVID-19 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
Merck
Shionogi
Frontier Biotechnologies
Simcere Pharmaceutical
Guangdong Zhongsheng
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Antiviral Medications for COVID-19 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Antiviral Medications for COVID-19, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Antiviral Medications for COVID-19 industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Antiviral Medications for COVID-19 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Antiviral Medications for COVID-19 introduction, etc. Oral Antiviral Medications for COVID-19 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Antiviral Medications for COVID-19 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices